Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Adenosine, N-methyl-2'-o-methyl-
2. 57821-29-1
3. A903628
4. N6-methyl-2'-o-methyladenosine:(2r,3r,4r,5r)-2-(hydroxymethyl)-4-methoxy-5-(6-(methylamino)-9h-purin-9-yl)tetrahydrofuran-3-ol
| Molecular Weight | 295.29 g/mol |
|---|---|
| Molecular Formula | C12H17N5O4 |
| XLogP3 | 0.2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 295.12805404 g/mol |
| Monoisotopic Mass | 295.12805404 g/mol |
| Topological Polar Surface Area | 115 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 363 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 4 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14874
Submission : 2000-05-10
Status : Inactive
Type : II


Registrant Name : Aju Pharmaceutical Co., Ltd.
Registration Date : 2013-01-31
Registration Number : 20121026-149-I-108-01(1)
Manufacturer Name : Alfasigma SpA@ OPOCRIN SpA
Manufacturer Address : Via ENRICO FERMI 1-65020 ALANNO(PE), ITALY@Via Pacinotti, 3 41043 CORLO Di FORMIGINE (Modena), Italy

Registrant Name : Pamirae Co., Ltd.
Registration Date : 2019-11-25
Registration Number : 20191125-149-I-563-02
Manufacturer Name : Biofer SpA
Manufacturer Address : Via Canina, 2, 41036 MEDOLLA (MO), ITALY


Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2012-10-26
Registration Number : 20121026-149-I-108-01
Manufacturer Name : Alfasigma SpA/@OPOCRIN SpA_x000D_ @Samoh Pharmaceutical Co., Ltd.
Manufacturer Address : Via Enrico Fermi 1-65020 Alanno (PE), Italy@Via Pacinotti, 3 41043 CORLO Di FORMIGINE (Modena), Italy_x000D_ @(135-925)7th floor, Samoh Building, 151 Yeoksam-ro, Gangnam-gu, Seoul _x000D_

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14874
Submission : 2000-05-10
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]About the Company : ENOMARK Group of Companies stands as a prominent Contract Manufacturer, boasting a cutting-edge manufacturing facility in Ahmadabad (Gujarat) that complies with WHO-GMP standards. ...

About the Company : Since its establishment in 1960 LDO has oriented its productions towards the extraction of active pharmaceutical ingredients from animal organs. Over the years, LDO has specialized...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Details:
Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of COVID-19.
Lead Product(s): Sulodexide,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Alfasigma
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 12, 2022

Lead Product(s) : Sulodexide,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Alfasigma
Deal Size : Inapplicable
Deal Type : Inapplicable
Endothelial Protection in Post COVID-19 Patients With Sulodexide
Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 12, 2022

Details:
Vessel (Sulodexide) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Vascular Diseases.
Lead Product(s): Sulodexide,Inapplicable
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Vessel
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Alfasigma
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 13, 2021

Lead Product(s) : Sulodexide,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Alfasigma
Deal Size : Inapplicable
Deal Type : Inapplicable
Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities
Details : Vessel (Sulodexide) is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Vascular Diseases.
Product Name : Vessel
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 13, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of COVID-19.
Lead Product(s): Sulodexide,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase II/ Phase IIIProduct Type: Miscellaneous
Sponsor: Clinedem
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 23, 2020

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sulodexide,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Partner/Sponsor/Collaborator : Clinedem
Deal Size : Inapplicable
Deal Type : Inapplicable
Suloexide in the Treatment of Early Stages of COVID-19
Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 23, 2020

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Peripheral Arterial Disease.
Lead Product(s): Sulodexide,Atorvastatin,Aspirin Lysinate,Captopril
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Poseidon CRO
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 12, 2017

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sulodexide,Atorvastatin,Aspirin Lysinate,Captopril
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Poseidon CRO
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Peripheral Arterial Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 12, 2017

Details:
Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Postthrombotic Syndrome.
Lead Product(s): Sulodexide,Inapplicable
Therapeutic Area: Hematology Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 31, 2015

Lead Product(s) : Sulodexide,Inapplicable
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Postthrombotic Syndrome.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 31, 2015

Details:
Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetic Nephropathies.
Lead Product(s): Sulodexide,Inapplicable
Therapeutic Area: Nephrology Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Miscellaneous
Sponsor: ALFA WASSERMANN(BJ) Market Research and Management Co., Ltd
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 16, 2011

Lead Product(s) : Sulodexide,Inapplicable
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : ALFA WASSERMANN(BJ) Market Research and Management Co., Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients
Details : Sulodexide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetic Nephropathies.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 16, 2011

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Italy
Brand Name : Vessel
Dosage Form :
Dosage Strength : 50 Cps 250 Uls
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Italy
Brand Name : Vessel
Dosage Form :
Dosage Strength : 10 Vials Im Ev 600 Uls/2 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Aterina
Dosage Form : Soft Capsule
Dosage Strength : 15MG
Packaging :
Approval Date : 1982-07-01
Application Number : 55545
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Aterina
Dosage Form : Injectable Solution
Dosage Strength : 60MG
Packaging :
Approval Date : 2018-01-15
Application Number : 82783
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Suspensed
Registration Country : Spain
Brand Name : Dovida
Dosage Form : Soft Capsule
Dosage Strength : 30MG
Packaging :
Approval Date : 2014-07-14
Application Number : 78901
Regulatory Info : Suspensed
Registration Country : Spain

Regulatory Info :
Registration Country : Italy
Brand Name : Provenal
Dosage Form :
Dosage Strength : 50 Cps 250 Uls
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Ravenol F
Dosage Form :
Dosage Strength : 50 Cps 250 Uls
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Angioflux
Dosage Form :
Dosage Strength : 50 Cps 250 Usl
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Treparin
Dosage Form :
Dosage Strength : 50 Cps 250 Lru
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Clarens
Dosage Form :
Dosage Strength : 50 Cps 250 Uls
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
Reply
14 Jan 2025
Reply
10 Jan 2025
Reply
09 Nov 2022
Reply
13 Nov 2021
Reply
18 Oct 2021
Reply
15 Dec 2020
Reply
20 Oct 2018
Reply
22 Sep 2018
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
60
PharmaCompass offers a list of Sulodexide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sulodexide manufacturer or Sulodexide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sulodexide manufacturer or Sulodexide supplier.
PharmaCompass also assists you with knowing the Sulodexide API Price utilized in the formulation of products. Sulodexide API Price is not always fixed or binding as the Sulodexide Price is obtained through a variety of data sources. The Sulodexide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sulodexide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulodexide, including repackagers and relabelers. The FDA regulates Sulodexide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulodexide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sulodexide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sulodexide supplier is an individual or a company that provides Sulodexide active pharmaceutical ingredient (API) or Sulodexide finished formulations upon request. The Sulodexide suppliers may include Sulodexide API manufacturers, exporters, distributors and traders.
click here to find a list of Sulodexide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sulodexide DMF (Drug Master File) is a document detailing the whole manufacturing process of Sulodexide active pharmaceutical ingredient (API) in detail. Different forms of Sulodexide DMFs exist exist since differing nations have different regulations, such as Sulodexide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sulodexide DMF submitted to regulatory agencies in the US is known as a USDMF. Sulodexide USDMF includes data on Sulodexide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sulodexide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sulodexide suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Sulodexide Drug Master File in Korea (Sulodexide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sulodexide. The MFDS reviews the Sulodexide KDMF as part of the drug registration process and uses the information provided in the Sulodexide KDMF to evaluate the safety and efficacy of the drug.
After submitting a Sulodexide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sulodexide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Sulodexide suppliers with KDMF on PharmaCompass.
Sulodexide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulodexide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulodexide GMP manufacturer or Sulodexide GMP API supplier for your needs.
A Sulodexide CoA (Certificate of Analysis) is a formal document that attests to Sulodexide's compliance with Sulodexide specifications and serves as a tool for batch-level quality control.
Sulodexide CoA mostly includes findings from lab analyses of a specific batch. For each Sulodexide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulodexide may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulodexide EP), Sulodexide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulodexide USP).